Milestones
- Romulus and Remus bornOct 2024Complete.
- Khaleesi bornJan 2025Complete.
- Public announcement7 Apr 2025Complete.
Most important updates
- 7 Apr 2025
Physics limits
- A few edits can't recreate a speciesDire and gray wolves differ at millions of DNA letters. 20 edits change looks, but not the full biology, behaviour or gut microbes of the extinct animal.
- Cloning is inefficientMoving a nucleus into an egg often fails to reprogram it properly; most cloned embryos don't make it to birth, so many eggs and surrogates are needed per animal.
- Behaviour isn't in the genes aloneWolves learn hunting and social behaviour from their pack. Animals raised by people can't learn how their extinct counterparts lived.
How it works

DNA from old bones
Colossal sequenced ancient DNA from a dire wolf tooth about 13,000 years old and a skull about 72,000 years old.
20 edits in gray wolf cells
Gray wolf cells from blood were edited at 14 genes to change size, coat and colour toward dire wolf traits.
Dogs as surrogates
Edited nuclei were placed in dog egg cells, and the embryos carried by domestic dog surrogate mothers.
Papers & demos
- Apr 2025paperOn the ancestry and evolution of the extinct dire wolf (preprint) (opens doi.org)Colossal's analysis of the dire wolf genome behind its edit choices.
Update log
Mon 7 Apr 2025
- Major: PressResearch
About Colossal Biosciences
Colossal Biosciences
De-extinction, dire wolf, woolly mammoth
Dallas company co-founded by Ben Lamm and George Church that edits living animals to carry traits of extinct ones: mammoth, thylacine, dodo, moa. In 2025 it announced wolf pups edited with dire wolf traits and 'woolly mice'.
- Apr 2025: announced three pups cloned from gray wolf cells with 20 edits in 14 genes chosen from ancient dire wolf DNA.
- Many scientists, including the IUCN wolf and dog experts, say they are modified gray wolves, not dire wolves.
- Reported in Jul 2026 to be raising at a $20–30B valuation, up from $10.2B in Jan 2025.
- Founded
- 20215 yrs
- Headquarters
- United States
- Status
- Private
- Valuation
- $10BprivateJan 2025
- Raised
- $350M2 rounds
- Last round
- Series C · $200MJan 2025$10B post
- Works in
- BiotechDe-extinction
- Coverage
- 2 programs · 7 updateslatest 1 Jul 2026checked 25 Sep
- Lead investors
- TWG GlobalUS Innovative Technology Fund
- Investors
- TWG Global
- People
- Ben Lamm (opens en.wikipedia.org)Co-founder and CEOGeorge Church (opens en.wikipedia.org)Co-founderBeth Shapiro (opens en.wikipedia.org)Chief Science Officer

